| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.24 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |